222 related articles for article (PubMed ID: 25994502)
1. Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.
Petrelli F; Pezzica E; Cabiddu M; Coinu A; Borgonovo K; Ghilardi M; Lonati V; Corti D; Barni S
J Gastrointest Cancer; 2015 Sep; 46(3):212-8. PubMed ID: 25994502
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.
Rogers AC; Winter DC; Heeney A; Gibbons D; Lugli A; Puppa G; Sheahan K
Br J Cancer; 2016 Sep; 115(7):831-40. PubMed ID: 27599041
[TBL] [Abstract][Full Text] [Related]
3. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
4. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion is a high risk factor for stage I/II colorectal cancer: a systematic review and meta-analysis.
Yuan H; Dong Q; Zheng B; Hu X; Xu JB; Tu S
Oncotarget; 2017 Jul; 8(28):46565-46579. PubMed ID: 28430621
[TBL] [Abstract][Full Text] [Related]
6. Early tumour shrinkage as a prognostic factor and surrogate end-point in colorectal cancer: a systematic review and pooled-analysis.
Petrelli F; Pietrantonio F; Cremolini C; Di Bartolomeo M; Coinu A; Lonati V; de Braud F; Barni S
Eur J Cancer; 2015 May; 51(7):800-7. PubMed ID: 25794604
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of micrometastases and isolated tumour cells in histologically negative lymph nodes of patients with colorectal cancer: a systematic review and meta-analysis.
Sloothaak DA; Sahami S; van der Zaag-Loonen HJ; van der Zaag ES; Tanis PJ; Bemelman WA; Buskens CJ
Eur J Surg Oncol; 2014 Mar; 40(3):263-9. PubMed ID: 24368050
[TBL] [Abstract][Full Text] [Related]
8. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
9. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
Zlobec I; Terracciano L; Tornillo L; Günthert U; Vuong T; Jass JR; Lugli A
Gut; 2008 Oct; 57(10):1413-9. PubMed ID: 18436576
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of perineural invasion in stages II and III colorectal cancer.
Zhou Y; Wang H; Gong H; Cao M; Zhang G; Wang Y
Pathol Res Pract; 2015 Nov; 211(11):839-44. PubMed ID: 26429129
[TBL] [Abstract][Full Text] [Related]
11. Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
Wu Y; Chen C; Hua X; Zhao C; Min H
BMC Cancer; 2024 Apr; 24(1):537. PubMed ID: 38678238
[TBL] [Abstract][Full Text] [Related]
12. The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: a systematic review.
van Wyk HC; Park J; Roxburgh C; Horgan P; Foulis A; McMillan DC
Cancer Treat Rev; 2015 Feb; 41(2):151-9. PubMed ID: 25549950
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
[TBL] [Abstract][Full Text] [Related]
14. Association of CDX2 Expression With Survival in Early Colorectal Cancer: A Systematic Review and Meta-analysis.
Tomasello G; Barni S; Turati L; Ghidini M; Pezzica E; Passalacqua R; Petrelli F
Clin Colorectal Cancer; 2018 Jun; 17(2):97-103. PubMed ID: 29519711
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
[TBL] [Abstract][Full Text] [Related]
16. Significance of extranodal tumour deposits in colorectal cancer: A systematic review and meta-analysis.
Lord AC; D'Souza N; Pucher PH; Moran BJ; Abulafi AM; Wotherspoon A; Rasheed S; Brown G
Eur J Cancer; 2017 Sep; 82():92-102. PubMed ID: 28651160
[TBL] [Abstract][Full Text] [Related]
17. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow micrometastasis is associated with both disease recurrence and poor survival in surgical patients with node-negative non-small-cell lung cancer: a meta-analysis.
Deng XF; Liu QX; Zhou D; Min JX; Dai JG
Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):21-7. PubMed ID: 25883247
[TBL] [Abstract][Full Text] [Related]
19. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
[TBL] [Abstract][Full Text] [Related]
20. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]